Photograph of Mary Anne Schofield, Ph.D.


  • Fordham University School of Law, J.D.
  • University of California, San Francisco, Ph.D
  • Molecular Biology Institute, UCLA, Postdoctoral Fellow
  • Polytechnic Institute of New York, B.S. Life Sciences


  • District of Columbia
  • New York
  • U.S. Patent and Trademark Office (USPTO)

Mary Anne Schofield, Ph.D.

Senior Counsel
Washington, D.C.
Phone: +1 202.624.2643
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Dr. Mary Anne Schofield is a senior counsel in the Intellectual Property Group in Crowell & Moring's Washington, D.C. office. She received her doctorate with Nobel laureate Harold Varmus at the University of California, San Francisco, where her research focused on mammalian cell transformation by Rous sarcoma virus phosphokinase, pp60v-src. As senior counsel, she focuses her practice on counseling not-for-profit, academic and industry clients in transactional matters, patent portfolio management, evaluation of intellectual property for clearance and right to use, and patent prosecution. Dr. Schofield also negotiates public-private collaboration agreements between multiple parties for disease-related scientific research and public dissemination of research results. She prepares opinions on infringement, validity, patentability, and freedom to operate. She drafts and prosecutes U.S. and international patent applications in the biotechnology and life sciences space relating to, among other things, transgenic animals and plants; medical processes; diagnostic and therapeutic methods; diagnostic and therapeutic compositions and reagent kits; novel nucleic acid molecules, protein products and methods for their production and use. 

Prior to practicing law, Dr. Schofield was a postdoctoral fellow at the Molecular Biology Institute, UCLA (1988-1991) investigating mutant bacterial strains with altered rates of gene rearrangements.


Admitted to practice: District of Columbia, New York, U.S. Patent and Trademark Office (USPTO)

Speeches & Presentations

  • "Biosimilar Biological Products," FDLI's Introduction to Biologics and Biosimilars Law and Regulation, Washington, D.C. (October 1, 2019). Presenters: Deborah H. Yellin and Mary Anne Schofield, Ph.D.

Client Alerts & Newsletters

Media Mentions